The African AIDS Vaccine Programme (AAVP)
Request for Small Grants Application
Background
Epidemiological data indicate that 70% of all HIV infections still occur in Africa and the high rates of HIV transmission across sub-Saharan Africa, emphasize the need to develop additional biomedical preventive tools such as preventive HIV vaccines, which are simple, affordable and effective.
The mission of the African AIDS Vaccine Programme (AAVP) is to advocate and support a coordinated effort to contribute to the global HIV vaccine development goals, ensuring that appropriate and affordable vaccines are developed for Africa in the shortest possible time.
AAVP is hosted and supported by the WHO-UNAIDS HIV Vaccine Initiative (HVI). It was conceived in 2000 as a network of African experts, working together to promote and facilitate HIV vaccine research and evaluation in Africa through capacity-building and regional and international collaboration.